{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:49:11Z","timestamp":1785268151939,"version":"3.55.0"},"reference-count":37,"publisher":"BMJ","issue":"Suppl 4","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2013,8,21]]},"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The aims of this study were to assess antimicrobial resistance in<jats:italic>Neisseria gonorrhoeae<\/jats:italic>infections and update the treatment in the national guidelines for the syndromic management of sexually transmitted infections in Morocco.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>171 men complaining of urethral discharge were recruited from basic health services during 2009. Urethral swab samples were collected and<jats:italic>N gonorrhoeae<\/jats:italic>identification was performed by culture. Antimicrobial susceptibility testing was performed using the Etest method and the antimicrobial agents tested were ciprofloxacin, penicillin, spectinomycin, tetracycline, ceftriaxone and cefixime.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 72 isolates were examined. Significant resistance to tetracycline (92.8%) and ciprofloxacin (86.8%), which was used as first-line treatment in gonococcal infections, was noted. No resistance to spectinomycin, ceftriaxone or cefixime was detected in all the isolates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Following these results the Ministry of Health of Morocco replaced ciprofloxacin and introduced ceftriaxone 250 mg as a single dose in the treatment of gonococcal infections. Using funds from the Global Fund to Fight AIDS, Tuberculosis and Malaria (the Global Fund), a surveillance programme was set up for antimicrobial resistance testing in<jats:italic>N gonorrhoeae<\/jats:italic>.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2013-051166","type":"journal-article","created":{"date-parts":[[2013,9,14]],"date-time":"2013-09-14T03:53:30Z","timestamp":1379130810000},"page":"iv24-iv27","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":12,"title":["Antimicrobial resistance monitoring in<i>Neisseria gonorrhoeae<\/i>and strategic use of funds from the Global Fund to set up a systematic Moroccan gonococcal antimicrobial surveillance programme"],"prefix":"10.1136","volume":"89","author":[{"given":"Amina","family":"Han\u00e7ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Ndowa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahija","family":"Bellaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziza","family":"Bennani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Kettani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reda","family":"Charof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajae El","family":"Aouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,9,13]]},"reference":[{"key":"2024051410210033000_89.Suppl_4.iv24.1","unstructured":"World Health Organization. Gonorrhoea\u2014Incidence rate (per 100,000 populations). WHO Regional Office for Europe. Centralized Information System for Infectious Diseases (CISID)\/Sexually Transmitted Infections (STI). http:\/\/data.euro.who.int\/cisid (accessed 27 Aug 2013)."},{"key":"2024051410210033000_89.Suppl_4.iv24.2","unstructured":"World Health Organization (WHO), Department of Reproductive Health and Research. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae . Geneva: WHO, 2012:1\u201336. http:\/\/www.who.int\/reproductivehealth\/publications\/rtis\/9789241503501 (accessed 27 Aug 2013)."},{"key":"2024051410210033000_89.Suppl_4.iv24.3","doi-asserted-by":"publisher","DOI":"10.1586\/eri.09.63"},{"issue":"(Suppl)","key":"2024051410210033000_89.Suppl_4.iv24.4","first-page":"s70","article-title":"Monitoring antimicrobial resistance for public health action","volume":"27","author":"Tapsall","year":"2003","journal-title":"Commun Dis Intell"},{"key":"2024051410210033000_89.Suppl_4.iv24.5","doi-asserted-by":"crossref","unstructured":"Jabeen K Nizamuddin S Irfan S . Increasing trend of resistance to penicillin, tetracycline, and fluoroquinolone resistance in Neisseria gonorrhoeae from Pakistan (1992\u20132009). J Trop Med, 2011;Article ID 960501.","DOI":"10.1155\/2011\/960501"},{"key":"2024051410210033000_89.Suppl_4.iv24.6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2807\/ese.16.42.19995-en","article-title":"The European gonococcal antimicrobial surveillance programme, 2009","volume":"16","author":"Cole","year":"2011","journal-title":"Eurosurveillance"},{"key":"2024051410210033000_89.Suppl_4.iv24.7","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm434"},{"key":"2024051410210033000_89.Suppl_4.iv24.8","unstructured":"Surveillance standards for antimicrobial resistance. WHO\/CDS\/CSR\/DRS\/2001. 5. Geneva: World Health Organization, 2001."},{"key":"2024051410210033000_89.Suppl_4.iv24.9","first-page":"928","article-title":"The antimicrobial resistance containment and surveillance approach\u2014a public health tool","volume":"82","author":"Simonsen","year":"2004","journal-title":"Bull World Health Organ"},{"key":"2024051410210033000_89.Suppl_4.iv24.10","first-page":"226","article-title":"Penicillin sensitivity of gonococci in Australia: the development of an Australian gonococcal surveillance program","volume":"60","author":"Tapsall","year":"1984","journal-title":"Br J Vener Dis"},{"key":"2024051410210033000_89.Suppl_4.iv24.11","first-page":"364","article-title":"The incidence of gonorrhoea and the antibiotic sensitivity of gonococci in Australia, 1981\u20131991","volume":"69","author":"Tapsall","year":"1993","journal-title":"Genitourin Med"},{"key":"2024051410210033000_89.Suppl_4.iv24.12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/OLQ.0b013e318214e306","article-title":"Antimicrobial resistant Gonorrhea in Atlanta: 1988\u20132006","volume":"38","author":"Dionne-Odom","year":"2011","journal-title":"Sex Transm Dis"},{"key":"2024051410210033000_89.Suppl_4.iv24.13","doi-asserted-by":"crossref","first-page":"pii 19533","DOI":"10.2807\/ese.15.14.19533-en","article-title":"The Russian gonococcal antimicrobial susceptibility programme (RU-GASP)\u2014national resistance prevalence in 2007 and 2008, and trends during 2005\u20132008","volume":"15","author":"Kubanova","year":"2010","journal-title":"Euro Surveill"},{"key":"2024051410210033000_89.Suppl_4.iv24.14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl265"},{"key":"2024051410210033000_89.Suppl_4.iv24.15","doi-asserted-by":"publisher","DOI":"10.4103\/0974-777X.68537"},{"key":"2024051410210033000_89.Suppl_4.iv24.16","unstructured":"Tapsall JW . Antibiotic resistance in Neisseria gonorrhoeae . Geneva: Word Health Organization, 2001."},{"key":"2024051410210033000_89.Suppl_4.iv24.17","first-page":"1275","article-title":"Threat to cefixime treatment of gonorrhea","volume":"13","author":"Yokoi","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"2024051410210033000_89.Suppl_4.iv24.18","doi-asserted-by":"crossref","first-page":"pii 20200","DOI":"10.2807\/ese.17.25.20200-en","article-title":"Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011","volume":"17","author":"Unemo","year":"2012","journal-title":"Euro Surveill"},{"key":"2024051410210033000_89.Suppl_4.iv24.19","first-page":"199","article-title":"Detection of multidrug-resistant gonorrhoea in the Gauteng province","volume":"27","author":"Lewis","year":"2012","journal-title":"South Afr J Epidemiol Infect"},{"key":"2024051410210033000_89.Suppl_4.iv24.20","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.05760-11"},{"key":"2024051410210033000_89.Suppl_4.iv24.21","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00325-11"},{"key":"2024051410210033000_89.Suppl_4.iv24.22","unstructured":"Clinical and Laboratory Standard Institute. Performance Standards for Antimicrobial Susceptibility Testing; Seventeenth Informational Supplement. CLSI document M100-S17. Clinical and Laboratory Standards Institute 2007;27:1\u2013182."},{"key":"2024051410210033000_89.Suppl_4.iv24.23","first-page":"794","article-title":"Les \u00e9coulements ur\u00e9traux au Maroc: Pr\u00e9valence des germes et sensibilit\u00e9 du gonocoque","volume":"8","author":"Alami","year":"2002","journal-title":"La Revue de la M\u00e9diterran\u00e9e orientale"},{"key":"2024051410210033000_89.Suppl_4.iv24.24","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/155.4.819"},{"key":"2024051410210033000_89.Suppl_4.iv24.25","unstructured":"Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 1997. Division of STD Prevention, September 1998."},{"key":"2024051410210033000_89.Suppl_4.iv24.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(98)90975-0"},{"key":"2024051410210033000_89.Suppl_4.iv24.27","doi-asserted-by":"publisher","DOI":"10.1258\/0956462991913204"},{"key":"2024051410210033000_89.Suppl_4.iv24.28","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.46401-0"},{"key":"2024051410210033000_89.Suppl_4.iv24.29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00007435-200306000-00010","article-title":"Alarming increase in ciprofloxacin and penicillin resistant Neisseria gonorrhoeae isolates in New Delhi, India","volume":"30","author":"Bala","year":"2003","journal-title":"Sex Transm Dis"},{"key":"2024051410210033000_89.Suppl_4.iv24.30","first-page":"90","article-title":"High prevalence of Neisseria gonorrhoeae strains with reduced susceptibility to fluoroquinolones in Japan","volume":"70","author":"Tanaka","year":"1994","journal-title":"Genitourin Med"},{"key":"2024051410210033000_89.Suppl_4.iv24.31","first-page":"1041","article-title":"Increases in fluoroquinolone-resistant Neisseria gonorrhoeae-Hawaii and California, 2001","volume-title":"MMWR Morb Mortal Wkly Rep","volume":"51","author":"Centers for Disease Control and Prevention (CDC)","year":"2002"},{"key":"2024051410210033000_89.Suppl_4.iv24.32","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/jac\/dkp118","article-title":"Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy","volume":"63","author":"Starnino","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"2024051410210033000_89.Suppl_4.iv24.33","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-002-0204-8"},{"key":"2024051410210033000_89.Suppl_4.iv24.34","doi-asserted-by":"crossref","unstructured":"Unemo M Golparian D Syversen G . Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill 2010;15:pii 19721.","DOI":"10.2807\/ese.15.47.19721-en"},{"key":"2024051410210033000_89.Suppl_4.iv24.35","doi-asserted-by":"crossref","unstructured":"Unemo M Golparian D Stary A . First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill 2011;16:pii 19998.","DOI":"10.2807\/ese.16.43.19998-en"},{"key":"2024051410210033000_89.Suppl_4.iv24.36","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01604-06"},{"key":"2024051410210033000_89.Suppl_4.iv24.37","first-page":"95","article-title":"WHO Western Pacific and South East Asian gonococcal antimicrobial surveillance programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2010","volume":"36","author":"Lahra","year":"2012","journal-title":"Commun Dis Intell Q Rep"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2013-051166","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T17:21:35Z","timestamp":1715707295000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2013-051166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,13]]},"references-count":37,"journal-issue":{"issue":"Suppl 4","published-online":{"date-parts":[[2013,11,15]]},"published-print":{"date-parts":[[2013,12]]}},"alternative-id":["10.1136\/sextrans-2013-051166"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2013-051166","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,13]]}}}